http://www.reportbuyer.com/rss.htmlBuy the information you need on the General Pharmaceutical Industry. Our catalogue of reports includes specific data on Drug Markets and Global Biotechnology. Reports cover Europe, UK, USA, Asia and other global markets.en-gbReportbuyerservice@reportbuyer.comenquiries@redwiredesign.comhttp://www.reportbuyer.com/pharma_healthcare/general_industry/pharmaceuticals_industry_report_worldwide.htmlThe Global Pharmaceuticals Industry Report Do you know. . . . The top 7 best trading partners in the industry? Which company has the highest sales growth? Which companies have the highest levels of debt? This report is an in-depth financial evaluation of the global Pharmaceuticals industry. 4cd5f1801d6864da8a5f992733563da1Wed, 11 Nov 2009 12:00:00 GBPharma & Healthcare/General Industryhttp://www.reportbuyer.com/pharma_healthcare/general_industry/cliniques_medicales.htmlL'étude de Portefeuille Plimsoll - Cliniques Médicales - est une analyse détaillée du marché français. L'édition revue et corrigée 2009 examine la performance financière de chacune des sociétés qui comptent pour le succès de votre entreprise. Utilisant les dernières données disponibles, l'étude est un véritable outil de comparaison des résultats du marché et de votre propre entreprise. 707d9a28a4c0802622b8f08045982f97Sat, 10 Oct 2009 12:00:00 GBPharma & Healthcare/General Industryhttp://www.reportbuyer.com/pharma_healthcare/general_industry/laboratoires_danalyses_medicales.htmlL'étude de Portefeuille Plimsoll - Laboratoires D'analyses Médicales - est une analyse détaillée du marché français. L'édition revue et corrigée 2009 examine la performance financière de chacune des sociétés qui comptent pour le succès de votre entreprise. Utilisant les dernières données disponibles, l'étude est un véritable outil de comparaison des résultats du marché et de votre propre entreprise. dccc8ef7ca9f392624b5e07f9bde660aSat, 10 Oct 2009 12:00:00 GBPharma & Healthcare/General Industryhttp://www.reportbuyer.com/pharma_healthcare/general_industry/proteomics.htmlThis report describes and evaluates the proteomic technologies that will play an important role in drug discovery, molecular diagnostics and practice of medicine in the post-genomic era - the first decade of the 21st century. Most commonly used technologies are 2D gel electrophoresis for protein separation and analysis of proteins by mass spectrometry. Microanalytical protein characterization with multidimentional liquid chromatography/mass spectrometry improves the throughput and reliability of peptide mapping. 036e2095b042f88475f37be5db749e21Sat, 10 Oct 2009 12:00:00 GBPharma & Healthcare/General Industryhttp://www.reportbuyer.com/pharma_healthcare/general_industry/evolving_pharma_maa_landscape.htmlPharmaceutical industry growth rates have halved since 2003, and fell below 5% in 2008. The sector is under unprecedented pressure ??. 185e42e467710d2b5b9db9e607aecbcaWed, 09 Sep 2009 12:00:00 GBPharma & Healthcare/General Industryhttp://www.reportbuyer.com/pharma_healthcare/general_industry/recession_its_impact_pharamceutical_ma_activity.htmlExpert analysis and detailed case histories illuminate the effect on, and activities of, pharmaceutical companies in the current economic downturn. Expert analysis and detailed case histories illuminate the effect on, and activities of, pharmaceutical companies in the current economic downturn. Mergers and, more commonly, acquisitions have long been popular in the pharmaceutical industry. 30d41abf97ecf253dfd442ba0c0748eeWed, 09 Sep 2009 12:00:00 GBPharma & Healthcare/General Industryhttp://www.reportbuyer.com/pharma_healthcare/general_industry/world_pharmaceutical_markets_fact_book_2009.htmlFacts, figures, forecasts and statistics on pharmaceutical markets and companies around the world. In today's challenging market environment the need to understand world pharmaceutical marketplaces, and be able to answer quickly those questions that arise daily, is essential. Therefore an authoritative, current and comprehensive market intelligence source is an invaluable aid for every executive. 8ac4f07570c19aeaa49e106cf3203699Sat, 06 Jun 2009 12:00:00 GBPharma & Healthcare/General Industryhttp://www.reportbuyer.com/pharma_healthcare/general_industry/global_consumer_trends_health.html For 75% of consumers across 17 countries and 4 regions, "maintaining or improving health" has become more important to them in the 2 years since Datamonitor's 2007 report New Developments in Global Consumer Trends. This report outlines how over 40 health-driven trends influence consumer lifestyles and product choices globally and considers the implications and opportunities for industry players. Detailed trend analysis outlining what constitutes 'value' for consumers (trends are, after all, a reflection of what's important to consumers) Global in focus, but also offers country-by-country and category-by-category insights thereby catering to top-line or more specific information needs Covers all major FMCG sectors, but also with applicability to wider consumer goods audiences One of 10 dedicated mega-trend reports outlining the most important issues shaping global consumers' buying behavior both now and in the future Good trend-watching is about taking the bigger-picture approach. 2956854e26bdf15e02a5ac05a96daffaSat, 06 Jun 2009 12:00:00 GBPharma & Healthcare/General Industryhttp://www.reportbuyer.com/pharma_healthcare/general_industry/global_consumer_trends_individualism.html When surveyed by Datamonitor in August 2008, more than two thirds of respondents across the Asia Pacific region expressed the view that using specifically-designed products is 'important' or 'very important' to them. This is indicative of consumers' growing desire (across geographic territories) to be recognized as having 'personal needs' rather than being part of the 'mass market' Detailed trend analysis outlining what constitutes 'value' for consumers (trends are, after all, a reflection of what's important to consumers) Global in focus, but also offers country-by-country and sector insights thereby catering to top-line or more specific information needs Covers all major FMCG sectors, but also with applicability to wider consumer goods audiences One of 10 dedicated mega-trend reports outlining the most important issues shaping global consumers' buying behavior both now and in the future Good trend-watching is about taking the bigger-picture approach. Adopting a broader global perspective to trend-tracking facilitates better decision making by overcoming 'category myopia'. ada0321f21d1c1ada462298b2e031021Sat, 06 Jun 2009 12:00:00 GBPharma & Healthcare/General Industryhttp://www.reportbuyer.com/pharma_healthcare/general_industry/vitro_diagnostics_market_analysis_2009_2024.htmlNew innovative report discusses how the global IVD market will develop in light of commercial opportunities and high technological potential In vitro diagnostics constitute an important, growing healthcare industry and market, one that is increasingly biotechnological and closely aligned with pharma. In vitro diagnostic (IVD) tests provide essential information about physiological states, aiding diagnoses and choice of treatments. IVDs usefulness in drug development especially via biomarkers constitutes a major advance, and an expanding market opportunity. 6769c77ec451fabd69269dcd48e06449Tue, 05 May 2009 12:00:00 GBPharma & Healthcare/General Industryhttp://www.reportbuyer.com/pharma_healthcare/general_industry/u_s_state_local_emergency_response_c3_market_overview.htmlThis Frost & Sullivan research service titled U. S. State and Local Emergency Response C3 Market Overview provides a total market spending forecast, industry challenges and trends, and program overviews by state for command, control, and communications (C3). 7417373c650d756fb5c878c01dab5a58Tue, 05 May 2009 12:00:00 GBPharma & Healthcare/General Industryhttp://www.reportbuyer.com/pharma_healthcare/general_industry/report_traditional_chinese_medicine_industry_2009.htmlThe traditional Chinese medicine is Chinese traditional medical science. The traditional Chinese medicines mainly conclude traditional Chinese medical materials, traditional Chinese medicine pills and proprietary Chinese medicines. The traditional Chinese medical materials are the raw materials of the traditional Chinese medicine pills and the traditional Chinese medicine pills are the raw materials of the proprietary Chinese medicines. a99bcfef40cd9e3b17753616b0436ae6Sat, 04 Apr 2009 12:00:00 GBPharma & Healthcare/General Industryhttp://www.reportbuyer.com/pharma_healthcare/general_industry/mergers_aquisitions_pharmaceuticals_sector_2009.html"2009 is set to redefine the structure and dynamics of the pharmaceutical industry in a way not seen since the year 2000" On 26th January 2009, Pfizer announced plans to acquire Wyeth for $68 billion. Pfizer's CEO, Jeffrey B Kindler, insisted the deal would be different from the company's earlier mega-deals involving the acquisitions of Pharmacia (2002) and Warner-Lambert (2000) - the acquisition of Wyeth would provide a broad and diversified portfolio, rather than been focused on a single product or cost-cutting. Pfizer's strategy of growing its portfolio through a mega M&A deals follows the 2008 acquisitions of Millennium by Takeda and ImClone by Eli Lilly. b5dc1e75e209bdd71b4d348814add8c6Sat, 04 Apr 2009 12:00:00 GBPharma & Healthcare/General Industryhttp://www.reportbuyer.com/pharma_healthcare/general_industry/analyzing_major_pharmaceutical_markets.htmlThe Global Pharmaceutical Industry is the influencer and supplement of the health index of world populations. It is with the constant, untiring and accelerated efforts of this industry's constituents which ensure that countries can find health solutions for their citizens which are backed by world class R& D and provide the same at reasonable costs. The global pharmaceutical industry meets such regulatory and social challenges by developing country specific studies or coming up with drug lines for continents. 976b1fa7b6812baa894cf13316775872Wed, 01 Apr 2009 12:00:00 GBPharma & Healthcare/General Industryhttp://www.reportbuyer.com/pharma_healthcare/general_industry/looking_offshoring_pharmaceutical_industry.htmlThe organic spread of pharmaceutical industry worldwide has necessitated taking steps beyond only export of drug lifecycles across time based zones to development in those countries itself in order to capitalize on the opportunities present in these countries whether in terms of knowledge resources or as financial capabilities. These opportunities exist in terms of manufacturing API's or intermediate and final stage dugs. Offshoring is helping these companies develop application specific drugs, share knowledge and transmit the benefits of such research across the globe irrespective of borders. 9de5d51912c64ee8acff8fa9a7d53a0cWed, 01 Apr 2009 12:00:00 GBPharma & Healthcare/General Industryhttp://www.reportbuyer.com/pharma_healthcare/general_industry/analyzing_global_pharmaceutical_industry.htmlThe birth origins of the Pharmaceutical Industry can be traced back to more humble antecedents than just chemistry labs. The earliest incidents of recognition of the antiseptic properties of the dyestuffs is around the late 19th century. The invention of penicillin can yet be recognized as a major milestone for the emergent industry which firmly consolidated its R&D efforts in the 1950's. 3196b8da2fb94055e83fec0352678bb0Wed, 01 Apr 2009 12:00:00 GBPharma & Healthcare/General Industryhttp://www.reportbuyer.com/pharma_healthcare/general_industry/freedonia_focus_ethical_pharmaceuticals.htmlThis report discusses US ethical pharmaceuticals for the years 2003 and 2008, with forecasts for 2013. Topics covered include market size, regulatory and commercial status, product segmentation, health care funding, regulatory considerations, market environment, regulatory and commercial status forecasts, product forecasts, industry composition and leading participants. Product segments cover central nervous system agents, hormones and related agents, cardiovascular agents, anti-infective agents, respiratory agents, and other agents. f12c33603b0d88bc4fd404133c9f2970Tue, 03 Mar 2009 12:00:00 GBPharma & Healthcare/General Industryhttp://www.reportbuyer.com/pharma_healthcare/general_industry/opportunity_obama_economic_stimulus_bill_accelerate_personalized_medicine.htmlThis Health Industry Insights Perspective provides insights on some of the many ways that the recently passed American Recovery and Reinvestment Act of 2009 (i. e. , the Obama economic stimulus bill) can be expected to accelerate the broad adoption of personalized medicine (PM) in the United States. 8dfa5dc93f6e5af8a6129bc42d45be61Tue, 03 Mar 2009 12:00:00 GBPharma & Healthcare/General Industryhttp://www.reportbuyer.com/pharma_healthcare/general_industry/prescription_drug_wholesaling_us.htmlGeneric Symptoms The widespreading popularity of cheaper generic drugs and wholesale bypass are mainly responsible for the weakening health of pharmaceutical drug wholesalers. However, the prognosis is solid and as the US is the largest consumer of prescription drugs in the world, more sophisticated diagnostic processes and drugs are constantly evolving. This industry comprises establishments primarily engaged in wholesaling biological and medical products; botanical drugs and herbs; and pharmaceutical products intended for internal and external consumption in such forms as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions. ab0a5766720ea54a4717d49e10fa64c5Tue, 03 Mar 2009 12:00:00 GBPharma & Healthcare/General Industryhttp://www.reportbuyer.com/pharma_healthcare/general_industry/cosmetic_surgery_procedures_products.htmlThis report analyzes the US and the European markets for Cosmetic Surgery Procedures and Products in Millions of US$. The US market is analyzed in terms of both Cosmetic Surgery Products, and Cosmetic Surgery Procedures for the period 2006 through 2015. Major Cosmetic Surgery Products analyzed for the US market include Equipment (Lasers, Microdermabrators and Other Equipment), Injectables (Botulinum Toxin Type A, Dermal Fillers, and Other Injectables), Implants (Breast Implants and Other Implants), and Other Markets. 48d85c76bed367b0f6e4ec7dd3093d9eMon, 02 Feb 2009 12:00:00 GBPharma & Healthcare/General Industry